Position in ABBV
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$5,566,025
+$816,261 QoQ
Shares Held
22,119
+1.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
4.47%
of 13F equity value
Holder Rank
#1,247
of 4,153 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Haven Capital Group, Inc. holds $6,551,690 across 4 Drug Manufacturers - General names. ABBV ranks #1 (85.0% of the industry book) .
All Filings in ABBV
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,566,025 | 22,119 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $4,749,764 | 21,839 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $4,933,327 | 21,591 | Shares | Defined | 2026-01-15 | |
| 2025-09-30 | $4,992,233 | 21,561 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $4,045,402 | 21,794 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $4,693,038 | 22,399 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $4,095,274 | 23,046 | Shares | Sole | 2025-02-10 | |
| No filing history on record for this holder in this stock. | ||||||